On ECHEMI
Home > Drugs > Benign prostatic hyperplasia
Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a disease mainly caused by the disorder of sex hormone metabolism in the elderly, which leads to the proliferation of glands and (or) fibers and muscle tissues to varying degrees, resulting in an increase in the size of the prostate, destruction of normal structure and a series of functional disorders. Benign prostatic hyperplasia is a common disease in middle-aged and elderly men, and about half of men over 50 years old will have clinical symptoms. The enlarged prostate squeezes the urethra, leading to a series of urination disorders, such as frequent urination, urgency, weak urine flow, and incomplete urination. These symptoms seriously affect the patient's quality of life. Failure to treat them in time can lead to many serious complications (such as acute urinary retention, stones, renal insufficiency, etc.), and may even endanger the patient's life.
  • Site of disease:

    prostate
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Painful urination Urgency Frequent urination Acute urinary retention Incomplete bladder emptying
  • Concurrent disease:

Related Drugs
Terazosin Hydrochloride Tablets
Indication: It is used to treat patients with hypertension, and can be used alone or simultaneously with other antihypertensive drugs.
Manufacturer:

Shanghai Yan’an Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Capsules
Manufacturer:

Yangzhou NO.3 Pharmacitical Manufacture Co., Ltd.

High-Terlin Terazosin Hydrochloride Tablets
Indication: This product is suitable for the treatment of mild or moderate hypertension when taken orally. It can be used in combination with thiazide diuretics or other antihypertensive drugs. It can also be used alone when other drugs are not suitable or ineffective. This product mainly reduces diastolic blood pressure. This product is also suitable for the symptomatic treatment of urinary retention caused by benign prostatic hyperplasia (BPH).
Terazosin Hydrochloride
Indication: It is used to treat mild or moderate hypertension. It can be used alone or in combination with other antihypertensive drugs such as thiazide diuretics or beta-blockers. It is used to relieve obstructive symptoms of benign prostatic hyperplasia (BPH).
Naftopidil
Indication: Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH).
Naftopidil
Indication: Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH).
Manufacturer:

Tonghua Jitong Medical Co., Ltd.

Naftopidil
Indication: Used to relieve urinary tract obstruction symptoms caused by benign prostatic hyperplasia (BPH).
Manufacturer:

Hainan Simcere Pharmaceutical Co., Ltd.

Finasteride Dispersible Tablets
Indication: This product is suitable for the treatment of symptomatic benign prostatic hyperplasia (BPH): - Improve symptoms. - Reduce the risk of acute urinary retention. - Reduce the risk of transurethral resection of the prostate (TURP) and prostatectomy.
Longkai Granules
Manufacturer:

Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.

Longkai Granules
Manufacturer:

Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.